Since SMC migration and vascular remodeling are important processes for the development of hypertension, these data suggest that the DAPK3/p38/HSP27 axis might be a potential pharmaceutical target for the prevention of hypertensive cardiovascular diseases [80]. The gene discussed is DAPK3; the disease is hypertensive heart disease.